AI will deliver transformative therapies at an exponential scale, addressing the complexities of biology that traditional ...

At Clone, a pioneering robotics company headquartered in Poland and California, Wiktoria Kruk, Vice President of Biomechanics ...

The natural protein, known as CelOCE, was developed at the Brazilian Center for Research in Energy and Materials and is ready ...

Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, and Ingredion Incorporated , a leading global provider of ingredient ...

Amyris, Inc., a vertically integrated synthetic biology company and leading innovator in the field of industrial biotechnology, today announced that it has acquired Ingredion's 31% stake in ...

The formation of the ISRO-DBT Joint Working Group is a mission-critical step to realize the full potential of this ...

Researchers at the Max Planck Institute for Evolutionary Anthropology have addressed a longstanding challenge in CRISPR ...

In this era of escalating trade tensions and geopolitical uncertainty, the U.S. cannot afford to cede another critical ...

Using Gibson SOLA at scale is intended to contribute to an agile and efficient approach to biologics discovery. The Gibson SOLA platform has been shown to enable fully-enzymatic, overnight, on-site ...

Looking back on research tools & consumables stocks’ Q1 earnings, we examine this quarter’s best and worst performers, ...

A new antivenom relies on antibodies from the blood of Tim Friede, who immunized himself against snakebites by injecting increasing doses of venom into his body.